Poster zum Thema "Population Proteomics in Health and Disease"

Zurück
  • P-I-0205
Plasma cytokine profiles in the SHIP-TREND-0 cohort – associations with age, sex and BMI
  • Sabine Ameling (Greifswald / DE)
  • P-I-0206
Pre-existing immunity effects on viral infections and vaccinations
  • P-I-0207
Trans-pandemic population profiling in young adults
  • P-I-0208
In-depth plasma proteome from patients with post-viral neurocognitive disorders: a pilot study
  • P-I-0209
Protein signatures across multiple neurodegenerative diseases
  • P-I-0210
Persistent antibody clones dominate the plasma antibody repertoire
  • P-I-0211
In-depth crude plasma micro-flow LC-MS/MS profiling for disease understanding and biomarkers discovery using novel tandem UHPLC workflow and on-line coupled columns
  • P-I-0212
Empowering robust population-scale MS plasma proteomics studies with nanoparticle enrichment
  • P-I-0213
Large-scale protein-disease risk association analysis in the UK Biobank: Introducing an extensive and freely available research resource in Olink® Insight
  • P-I-0214
Proteomics profiling of normal and tumoral human colon stem and epithelial cell populations
  • P-I-0215
Mitochondrial dynamics in gastric cancer: contrasting diffuse and intestinal types
  • P-I-0216
Analyzing the proteome, N-glycoproteome and phosphoproteome of dried blood: method optimization and application to phenotyping of human sepsis
  • P-I-0218
Exploring the spectrum of human encounters with bacterial pathogens by profiling pathogen-specific antibody repertoires in a population-based setting using the SHIP-TREND cohort
  • P-I-0219
Challenges of scientific project management in the SMART-CARE consortium
  • P-I-0220
Proteomics as a bridge between genomics and human health: a systematic approach to identify therapeutic targets in large population health cohorts like the UK biobank
  • P-I-0221
Assessing the role of protein variants in modulating protein-protein interaction networks by a quantitative interactomics approach
  • P-I-0222
Follicular fluid peptidomics: understanding Oocyte reproductive potential
  • P-I-0223
Facilitating large-scale proteomics by combining automated sample preparation with short gradient LC-MS acquisitions
  • P-I-0224
Pediatric proteomics: a systematic approach to deciphering disease and enhancing early intervention
  • P-I-0225
Profiling of the peripheral blood mononuclear cells proteome by shot-gun proteomics identifies alterations of immune components, proteolytic balance and mithocondrial metabolism in Glaucoma
  • P-I-0226
A network analysis approach to identify protein clusters and multi-Omic determinants of childhood respiratory-related diseases
  • P-I-0227
Plasma proteins associated with COVID-19 in unvaccinated and vaccinated Puerto Ricans
  • P-I-0228
Proteomic profiling of cancer-associated fibroblasts in squamous cell carcinoma
  • P-I-0229
Genetic atlas of human protein complexes
  • P-I-0230
Every hour counts: mapping neonatal blood plasma proteome changes during the first 2 days of life at hourly resolution
  • P-I-0231
Prediction of type 1 diabetes using proteomics
  • P-I-0232
Proteomic profiling of CSF and serum: non-linear progression and staging biomarkers for preclinical Alzheimer's disease
    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH